Accumulating research has revealed that the upregulation of LCP1 expression is closely associated with the development of a wide range of human tumors, including colorectal cancer, prostate cancer, breast cancer, and oral cancer [20, 21, 42–44]. Here, LCP1 is linked to breast carcinoma.